Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid leukemia

CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT.

Bone marrow transplantation·2013

A simple and rapid immunomagnetobead technique for the analysis of platelet glycoprotein deficiencies.

Platelets·2010

The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.

Bone marrow transplantation·2008

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

Journal of thrombosis and haemostasis : JTH·2006

Transplantation strategies in AML: AMLCG data.

Annals of hematology·2004

Thalidomide for the treatment of acute myeloid leukemia.

Leukemia & lymphoma·2003

Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

American journal of hematology·2026

Primary Plasma Cell Leukemia.

American journal of hematology·2026

Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

American journal of hematology·2026

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

American journal of hematology·2026

Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.

American journal of hematology·2026

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

American journal of hematology·2026

Comprehensive leucocyte subsets assay in healthy adults using multiparametric flowcytometry.

The Indian journal of medical research·2026

Anti-CD6 monoclonal antibody UMCD6 induces CD6 internalization, remodels costimulatory receptor availability, and modulates CD4+ T-cell activation.

Frontiers in immunology·2026

A Cost-Effective Workflow for Mono- and Multiplex Immunofluorescence in Adherent Two-Dimensional Cell Cultures on Glass Coverslips.

Journal of visualized experiments : JoVE·2026

Planar Immunological Synapses Formed by Human CD4 T Cells as In Vitro System to Study Actin and Tubulin Dynamics Through TIRF Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026

Unicentric Castleman disease presenting as hyperenhancing mediastinal mass: A case series diagnosed by linear endobronchial ultrasound guided mediastinal nodal biopsy.

Lung India : official organ of Indian Chest Society·2026

Pretransfusion testing interference profile of IMC-002: A novel anti-CD47 monoclonal antibody engineered for minimized red cell binding.

Transfusion·2026

Related Experiment Videos

Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid

Related Concept Videos

CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT.

A simple and rapid immunomagnetobead technique for the analysis of platelet glycoprotein deficiencies.

The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

Transplantation strategies in AML: AMLCG data.

Thalidomide for the treatment of acute myeloid leukemia.

Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort.

Primary Plasma Cell Leukemia.

Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

Comprehensive leucocyte subsets assay in healthy adults using multiparametric flowcytometry.

Anti-CD6 monoclonal antibody UMCD6 induces CD6 internalization, remodels costimulatory receptor availability, and modulates CD4+ T-cell activation.

A Cost-Effective Workflow for Mono- and Multiplex Immunofluorescence in Adherent Two-Dimensional Cell Cultures on Glass Coverslips.

Planar Immunological Synapses Formed by Human CD4 T Cells as In Vitro System to Study Actin and Tubulin Dynamics Through TIRF Microscopy.

Unicentric Castleman disease presenting as hyperenhancing mediastinal mass: A case series diagnosed by linear endobronchial ultrasound guided mediastinal nodal biopsy.

Pretransfusion testing interference profile of IMC-002: A novel anti-CD47 monoclonal antibody engineered for minimized red cell binding.

Related Experiment Videos

Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid...

Related Concept Videos

Related Articles

Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid